Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Palbociclib Impurity 20 REF: 4Z-P-196024	- - -	To inquire	Tue 10 Dec 24
Abiraterone-d4 Sulfate Sodium Salt REF: 4Z-A-8243	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 45 REF: 4Z-L-124051	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 39 REF: 4Z-L-124045CAS: 2868-37-3	- - -	To inquire	Tue 10 Dec 24
Gimeracil N-Oxide REF: 4Z-G-047018	- - -	To inquire	Tue 10 Dec 24
Goserelin Impurity 3 (4-(Glycolyl-L-Serine)-Goserelin) REF: 4Z-PG-1518	- - -	To inquire	Tue 10 Dec 24
Abiraterone-β-D-Glucuronide REF: 4Z-A-826	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 16 REF: 4Z-L-124021CAS: 796848-79-8	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 18 REF: 4Z-P-196022CAS: 1244949-62-9	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 17 HCl REF: 4Z-B-119020	- - -	To inquire	Tue 10 Dec 24
Olaparib Metabolite M12 REF: 4Z-O-032034CAS: 2514757-44-7	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 48 REF: 4Z-E-068061CAS: 24115-24-0	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 53 REF: 4Z-C-121056CAS: 70637-26-2	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 25 REF: 4Z-N-066041	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 64 REF: 4Z-N-066082CAS: 1125-88-8	- - -	To inquire	Tue 10 Dec 24
Palbociclib Lactose adduct 1 REF: 4Z-P-196040	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 63 REF: 4Z-C-121066	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 20 REF: 4Z-B-119023CAS: 100564-98-5	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 86 REF: 4Z-N-066099	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 24 REF: 4Z-E-068037	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Palbociclib Impurity 20

Ref: 4Z-P-196024

Abiraterone-d4 Sulfate Sodium Salt

Ref: 4Z-A-8243

Lenvatinib Impurity 45

Ref: 4Z-L-124051

Lenvatinib Impurity 39

Ref: 4Z-L-124045

Gimeracil N-Oxide

Ref: 4Z-G-047018

Goserelin Impurity 3 (4-(Glycolyl-L-Serine)-Goserelin)

Ref: 4Z-PG-1518

Abiraterone-β-D-Glucuronide

Ref: 4Z-A-826

Lenvatinib Impurity 16

Ref: 4Z-L-124021

Palbociclib Impurity 18

Ref: 4Z-P-196022

Bestatin Impurity 17 HCl

Ref: 4Z-B-119020

Olaparib Metabolite M12

Ref: 4Z-O-032034

Enzalutamide Impurity 48

Ref: 4Z-E-068061

Carfilzomib Impurity 53

Ref: 4Z-C-121056

Nintedanib Impurity 25

Ref: 4Z-N-066041

Nintedanib Impurity 64

Ref: 4Z-N-066082

Palbociclib Lactose adduct 1

Ref: 4Z-P-196040

Carfilzomib Impurity 63

Ref: 4Z-C-121066

Bestatin Impurity 20

Ref: 4Z-B-119023

Nintedanib Impurity 86

Ref: 4Z-N-066099

Enzalutamide Impurity 24

Ref: 4Z-E-068037